22 May 2013
Keywords: pdl, hit, asthma, drug, failure, protein, design
Article | 19 May 2003
Protein Design Labs has reported that data from a Phase IIa trial of its humanized anti-interleukin-4 antibody in steroid-naive, mild-to-moderate
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
19 May 2003
© 2013 thepharmaletter.com